Abbott agrees to settlement over closure of largest baby formula plant in the U.S.

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: STAT
Abbott agrees to settlement over closure of largest baby formula plant in the U.S.WorldPing
Image via STAT.

What happened

Abbott has agreed to a $385 million settlement over the closure of the largest baby formula plant in the U.S., which led to the supply shortages in 2022.

Key facts

  • Abbott has agreed to a $385 million settlement over the closure of the largest baby formula plant in the U.S., which led to the supply shortages in 2022.
  • Reported by STAT and published Mon, 14 Sep 2026 19:18:37 UTC.

Why it matters

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

What to watch next

  • Case numbers and official guidance updates
  • Regulatory decisions in other countries
  • Supply, recall or access changes

Sources

The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at STAT

Follow the story

Living hubs that keep updating as this story develops.

Related WorldPing coverage

Abbott to pay $385M to settle US claims over infant formula plantWorldPing
Times of India

Abbott to pay $385M to settle US claims over infant formula plant

Abbott has agreed to pay nearly $385 million to resolve alleged false claims involving infant formula made at its Michigan facility. The settlement follows the company’s 2022 recall and plant closure amid contamination concerns.

Brief by WorldPing · Original reporting by Times of India